Biomarkers

Building a Bioanalytical Strategy for Asset Optimization & Risk Management in Drug Development

April 19, 2023
Blogs

Amgen Launches Humira Biosimilar Amjevita + Potential New Blood Test for Early Detection of Alzheimer’s – Xtalks Life Science Podcast Ep. 96

Creating Digital Biomarkers with Real-World and Existing Data

February 02, 2023

Liquid Biopsy Assays: Beyond Recurrence Detection in Post-Diagnosis Cancer Management

December 02, 2022

Next-Generation Sequencing Applications for Antiviral Drug Development & FDA Guidance for Data Submission

November 11, 2022

Clinically-Relevant Biomarker Strategies in Drug Development and the Potential of Machine-Learning for Biomarker Assessment

November 18, 2022
Blogs

FDA Issues Safety Warning for Blood Cancer Drug + Long COVID Risk Assessment Tool – Xtalks Life Science Podcast Ep. 68

Alternative Approaches to Functional and Phenotypic Assays Using Multiparameter Flow Cytometry

July 26, 2022
Life Science News

FDA Approves Bristol Myers’ Cardiac Drug for HCM + New Ovarian Cancer Blood Test – Xtalks Life Science Podcast Ep. 60
Medical Device Diagnostics News

Researchers Use Emerging Ovarian Cancer Biomarker to Develop New Blood Test for Ovarian Cancer

A Review of Current Biomarkers for Alzheimer’s Disease

February 24, 2022

Breast Cancer Biomarkers: The Emerging Role of Immune and Digital Biomarkers and the Benefits of Parallel CDx Development

October 27, 2021
Blogs

World’s First Smart Knee + Alzheimer’s Blood Test – Xtalks Life Science Podcast Ep. 27
Medical Device Clinical Trials News

New Study Shows Diadem’s AlzoSure Alzheimer’s Blood Test Can Predict Disease Years Before Diagnosis

Biomarkers for Neurodegenerative Diseases: Immunoassays and LC-MS/MS to Track Disease Progression

October 12, 2021
Blogs

COVID-19 Impacts on Cognitive Health + Pancreatic Cancer Blood Test Ep. 23